Cigna Group
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
CI$293.59-2.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FS-4
STATEMENTS OF CASH FLOWS
| For the Years Ended December 31, | |||||
|---|---|---|---|---|---|
| (In millions) | 2023 | 2022 (1) | 2021 (1) | ||
| Cash Flows from Operating Activities | |||||
| Shareholders' net income | $5,164 | $6,704 | $5,370 | ||
| Adjustments to reconcile shareholders' net income | |||||
| to net cash provided by operating activities | |||||
| Equity in income of subsidiaries | (5,886) | (7,402) | (6,068) | ||
| Debt extinguishment costs | — | — | 131 | ||
| Dividends received from subsidiaries | 1,381 | 2,056 | 2,726 | ||
| Other liabilities | 540 | 5 | 184 | ||
| Other, net | 640 | 298 | 439 | ||
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 1,839 | 1,661 | 2,782 | ||
| Cash Flows from Investing Activities | |||||
| Net change in amounts due from affiliates | 622 | (901) | (1,007) | ||
| Net proceeds from short-term investments sold (purchased) | — | 99 | (50) | ||
| NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES | 622 | (802) | (1,057) | ||
| Cash Flows from Financing Activities | |||||
| Net change in amounts due to affiliates | 1,473 | 10,392 | 2,062 | ||
| Net change in commercial paper | 1,237 | (2,027) | 997 | ||
| Payments for debt extinguishment | — | — | (126) | ||
| Repayment of long-term debt | (2,822) | (430) | (4,199) | ||
| Net proceeds on issuance of long-term debt | 1,491 | — | 4,260 | ||
| Issuance of common stock | 187 | 389 | 326 | ||
| Common dividends paid | (1,450) | (1,384) | (1,341) | ||
| Repurchase of common stock | (2,284) | (7,607) | (7,742) | ||
| Tax withholding on stock compensation and other | (110) | (73) | (86) | ||
| NET CASH USED IN FINANCING ACTIVITIES | (2,278) | (740) | (5,849) | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 183 | 119 | (4,124) | ||
| Cash, cash equivalents and restricted cash, beginning of year | 152 | 33 | 4,157 | ||
| Cash, cash equivalents and restricted cash, end of year (2) | $335 | $152 | $33 | ||
| Noncash Investing and Financing Activities: | |||||
| Net amounts due to/(from) affiliates settled through capital transactions | (5,221) | (5,037) | (8,429) | ||
(2) Includes restricted cash reported in Other non-current assets as of December 31, 2023 and December 31, 2022.
FS-4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.